Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1988 Jun;63(6):629–634. doi: 10.1136/adc.63.6.629

Growth hormone releasing hormone or growth hormone treatment in growth hormone insufficiency?

P J Smith 1, C G Brook 1
PMCID: PMC1778849  PMID: 2898924

Abstract

Sixteen prepubertal children who were insufficient for growth hormone were treated with growth hormone releasing hormone (GHRH) 1-40 and GHRH 1-29 for a mean time of nine months (range 6-12 months) with each peptide. Eleven children received GHRH 1-40 in four subcutaneous nocturnal pulses (dose 4-8 micrograms/kg/day) and eight (three of whom were also treated with GHRH 1-40) received GHRH 1-29 twice daily (dose 8-16 micrograms/kg/day). Altogether 73% of the children receiving GHRH 1-40 and 63% receiving GHRH 1-29 showed a growth response. Double the daily dose of GHRH 1-29 was required to obtain equivalent growth response to pulsatile GHRH 1-40. A significant linear correlation was shown between growth hormone secretion and height velocity on GHRH 1-40 but not on GHRH 1-29 and there was a significant correlation between plasma GHRH and serum growth hormone concentrations during GHRH 1-40 administration. Response to conventional growth hormone treatment in a matched group of children was significantly better than the response after GHRH. A significant improvement in height velocity was observed in the children transferred to growth hormone replacement. Growth hormone remains the treatment of choice in growth hormone insufficiency. GHRH treatment may be of benefit in children with less severe growth hormone insufficiency in the presence of pulsatile endogenous growth hormone secretion.

Full text

PDF
629

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Grossman A., Savage M. O., Lytras N., Preece M. A., Sueiras-Diaz J., Coy D. H., Rees L. H., Besser G. M. Responses to analogues of growth hormone-releasing hormone in normal subjects, and in growth-hormone deficient children and young adults. Clin Endocrinol (Oxf) 1984 Sep;21(3):321–330. doi: 10.1111/j.1365-2265.1984.tb03477.x. [DOI] [PubMed] [Google Scholar]
  2. Hümmelink R., Rohwedder R., Sippell W. G. Nine months' subcutaneous therapy with synthetic growth hormone releasing factor in children with short stature. Acta Paediatr Scand Suppl. 1987;331:48–52. doi: 10.1111/j.1651-2227.1987.tb17098.x. [DOI] [PubMed] [Google Scholar]
  3. Krulich L., Dhariwal A. P., McCann S. M. Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology. 1968 Oct;83(4):783–790. doi: 10.1210/endo-83-4-783. [DOI] [PubMed] [Google Scholar]
  4. Rafferty B., Schulster D. Radioimmunoassay for human growth hormone-releasing factor (hGRF 1-40): comparison of plasma immunoreactive GRF after intravenous and subcutaneous administration to rats. Mol Cell Endocrinol. 1985 Jun;41(1):19–25. doi: 10.1016/0303-7207(85)90139-x. [DOI] [PubMed] [Google Scholar]
  5. Smith P. J., Brook C. G., Rivier J., Vale W., Thorner M. O. Nocturnal pulsatile growth hormone releasing hormone treatment in growth hormone deficiency. Clin Endocrinol (Oxf) 1986 Jul;25(1):35–44. doi: 10.1111/j.1365-2265.1986.tb03593.x. [DOI] [PubMed] [Google Scholar]
  6. Smith P. J., Brook C. G. The place of intravenous GHRH 1-40 studies in the therapy of growth hormone-deficient children with GHRH. Clin Endocrinol (Oxf) 1987 Jul;27(1):97–105. doi: 10.1111/j.1365-2265.1987.tb00844.x. [DOI] [PubMed] [Google Scholar]
  7. Tannenbaum G. S., Ling N. The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion. Endocrinology. 1984 Nov;115(5):1952–1957. doi: 10.1210/endo-115-5-1952. [DOI] [PubMed] [Google Scholar]
  8. Tannenbaum G. S., Martin J. B. Evidence for an endogenous ultradian rhythm governing growth hormone secretion in the rat. Endocrinology. 1976 Mar;98(3):562–570. doi: 10.1210/endo-98-3-562. [DOI] [PubMed] [Google Scholar]
  9. Tanner J. M., Whitehouse R. H., Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II. Arch Dis Child. 1966 Dec;41(220):613–635. doi: 10.1136/adc.41.220.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Thorner M. O., Reschke J., Chitwood J., Rogol A. D., Furlanetto R., Rivier J., Vale W., Blizzard R. M. Acceleration of growth in two children treated with human growth hormone-releasing factor. N Engl J Med. 1985 Jan 3;312(1):4–9. doi: 10.1056/NEJM198501033120102. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES